세계의 알레르기 면역요법 시장 보고서(2023년)

“Allergy Immunotherapy Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on allergy immunotherapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for allergy immunotherapy? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The allergy immunotherapy market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Allergy Type: Allergic Rhinitis; Asthma; Food Allergy; Venom Allergy; Other Allergy Types

• 2) By Treatment: Subcutaneous Immunotherapy (SCIT); Sublingual Immunotherapy; Specific Immunotherapy (SIT)

• 3) By Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy

• Companies Mentioned: LETI Pharma; Stallergenes Greer International AG; Allergy Therapeutics PLC.; ALK-Abello A/S; HAL Allergy B.V.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the allergy immunotherapy market are LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics PLC., ALK-Abello A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergo Pharma, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, and WOLW Pharma.

The global allergy immunotherapy market is expected to grow from $2.34 billion in 2022 to $2.59 billion in 2023 at a compound annual growth rate (CAGR) of 10.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The allergy immunotherapy market is expected to grow to $3.85 billion in 2027 at a CAGR of 10.4%.

The allergy immunotherapy market includes revenues earned by entities by providing monoclonal antibodies and immune checkpoint inhibitors therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

Allergy immunotherapy refers to a type of therapy used to avoid allergic reactions to things like house dust mites, grass pollen, and bee venom. Immunotherapy includes giving the patient increasingly higher dosages of the chemical or allergen they are allergic to.

Europe was the largest region in the allergy immunotherapy market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main allergy types in allergy immunotherapy are allergic rhinitis, asthma, food allergy, venom allergy, and others. Allergic rhinitis refers to a diagnosis connected to a collection of symptoms that affect the nose. The various treatments involved are immunotherapy (SCIT), sublingual immunotherapy and specific immunotherapy (SIT). The various channels include hospital pharmacy, retail pharmacy and online pharmacy.

The rising prevalence of allergic disorders is expected to propel the growth of the allergy immunotherapy market going forward. Allergic disorders refer to excessive immune responses to specific antigens. Immune responses that are inappropriately directed against intrinsic bodily parts (self) result in autoimmune diseases. Allergy immunotherapy is available to atopic people who have allergy disorders like IgE-mediated allergic rhinitis and allergic asthma brought on by inhaled allergens, including pollens and house dust mites (HDMs). For instance, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, in 2021, in the USA, nearly one-third of adults aged 18 and up suffered from a seasonal allergy, skin condition, or food allergy. Overall, seasonal allergy was the most common of the three allergies, with approximately one-quarter (25.7%) of adults diagnosed, followed by eczema (7.3%) and food allergy (6.2%). Women were more likely than men to be allergic to all three allergens. Also, the prevalence of seasonal allergy diagnoses was 24.7% in adults aged 18-44, 27.9% in adults aged 45-64, 26.4% in adults aged 65-74, and 21.7% in adults aged 75 and up. Therefore, the rising prevalence of allergic disorders is driving the growth of the allergy immunotherapy market.

Product innovations have emerged as the key trend gaining popularity in the allergy immunotherapy market. Major companies operating in the allergy immunotherapy market are developing innovative products to strengthen their position in the market. For instance, in December 2020, the European Commission, an executive body of the European Union, approved Aimmune's PALFORZIA as the first-ever treatment for peanut allergy in the European Union. Aimmune Therapeutics is a US-based biopharmaceutical company that specializes in the development of product candidates for the treatment of peanut and other food allergies. PALFORZIA is a sophisticated biologic drug that is administered using an organized dosing regimen based on a couple of centuries of oral immunotherapy (OIT) research. OIT involves ingesting specific allergenic proteins in very small amounts at first, followed by progressively increasing amounts, which can result in the ability to reduce allergies and the allergic response over time. This oral immunotherapy is indicated in patients aged 4-17 years with a confirmed peanut allergy diagnosis.

In October 2020, Nestle, a Switzerland-based nutrition, health, and wellness company, acquired Aimmune Therapeutics for an undisclosed amount. Through this acquisition, Nestle will continue its constant pursuit of innovative, science-based nutritional solutions to support healthier lives. Aimmune Therapeutics is a US-based biopharmaceutical company that is developing and bringing new treatments to people with potentially life-threatening food allergies, as well as allergy immunotherapy.

The countries covered in the allergy immunotherapy market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The allergy immunotherapy market research report is one of a series of new reports from The Business Research Company that provides allergy immunotherapy market statistics, including the allergy immunotherapy industry global market size, regional shares, competitors with allergy immunotherapy market share, detailed allergy immunotherapy market segments, market trends, and opportunities, and any further data you may need to thrive in the allergy immunotherapy industry. This allergy immunotherapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Table of Contents

1. Executive Summary

2. Allergy Immunotherapy Market Characteristics

3. Allergy Immunotherapy Market Trends And Strategies

4. Allergy Immunotherapy Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Allergy Immunotherapy Market
• 4.2. Ukraine-Russia War Impact On Allergy Immunotherapy Market
• 4.3. Impact Of High Inflation On Allergy Immunotherapy Market

5. Allergy Immunotherapy Market Size And Growth

• 5.1. Global Allergy Immunotherapy Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Allergy Immunotherapy Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Allergy Immunotherapy Market Segmentation

• 6.1. Global Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Allergic Rhinitis
• Asthma
• Food Allergy
• Venom Allergy
• Other Allergy Types
• 6.2. Global Allergy Immunotherapy Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Subcutaneous Immunotherapy (SCIT)
• Sublingual Immunotherapy
• Specific Immunotherapy (SIT)
• 6.3. Global Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

7. Allergy Immunotherapy Market Regional And Country Analysis

• 7.1. Global Allergy Immunotherapy Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Allergy Immunotherapy Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Allergy Immunotherapy Market

• 8.1. Asia-Pacific Allergy Immunotherapy Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Allergy Immunotherapy Market

• 9.1. China Allergy Immunotherapy Market Overview
• 9.2. China Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Allergy Immunotherapy Market

• 10.1. India Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Allergy Immunotherapy Market

• 11.1. Japan Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Allergy Immunotherapy Market

• 12.1. Australia Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Allergy Immunotherapy Market

• 13.1. Indonesia Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Allergy Immunotherapy Market

• 14.1. South Korea Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Allergy Immunotherapy Market

• 15.1. Western Europe Allergy Immunotherapy Market Overview
• 15.2. Western Europe Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Allergy Immunotherapy Market

• 16.1. UK Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Allergy Immunotherapy Market

• 17.1. Germany Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Allergy Immunotherapy Market

• 18.1. France Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Allergy Immunotherapy Market

• 19.1. Eastern Europe Allergy Immunotherapy Market Overview
• 19.2. Eastern Europe Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Allergy Immunotherapy Market

• 20.1. Russia Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Allergy Immunotherapy Market

• 21.1. North America Allergy Immunotherapy Market Overview
• 21.2. North America Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Allergy Immunotherapy Market

• 22.1. USA Allergy Immunotherapy Market Overview
• 22.2. USA Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Allergy Immunotherapy Market

• 23.1. South America Allergy Immunotherapy Market Overview
• 23.2. South America Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Allergy Immunotherapy Market

• 24.1. Brazil Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Allergy Immunotherapy Market

• 25.1. Middle East Allergy Immunotherapy Market Overview
• 25.2. Middle East Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Allergy Immunotherapy Market

• 26.1. Africa Allergy Immunotherapy Market Overview
• 26.2. Africa Allergy Immunotherapy Market, Segmentation By Allergy Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Allergy Immunotherapy Market, Segmentation By Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Allergy Immunotherapy Market Competitive Landscape And Company Profiles

• 27.1. Allergy Immunotherapy Market Competitive Landscape
• 27.2. Allergy Immunotherapy Market Company Profiles
  • 27.2.1. LETI Pharma
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Stallergenes Greer International AG
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Allergy Therapeutics PLC.
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. ALK-Abello A/S
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. HAL Allergy B.V.
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Allergy Immunotherapy Market

29. Allergy Immunotherapy Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer